id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2672-0004,FDA,FDA-2022-N-2672,Public Meeting: Draft Amended Environmental Assessment Concerning AquAdvantage Salmon,Other,Environmental assessment,2022-12-16T05:00:00Z,2022,12,2022-12-16T05:00:00Z,,2022-12-16T16:09:16Z,,0,0,0900006485534aea
FDA-2022-N-2672-0005,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada - Presentation",Other,Environmental assessment,2022-12-16T05:00:00Z,2022,12,2022-12-16T05:00:00Z,,2022-12-16T16:09:23Z,,0,0,0900006485534aec
FDA-2022-N-2672-0002,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Public Meeting; Request for Comments",Notice,Public Meetings,2022-11-17T05:00:00Z,2022,11,2022-11-17T05:00:00Z,2023-01-18T04:59:59Z,2023-01-24T02:01:08Z,2022-25002,0,0,09000064854bdfde
FDA-2022-N-2672-0003,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Availability; Request for Comments",Notice,Notice of Availability,2022-11-17T05:00:00Z,2022,11,2022-11-17T05:00:00Z,2023-01-18T04:59:59Z,2023-01-19T02:01:06Z,2022-25001,0,0,09000064854bdfe4
FDA-2022-N-2672-0001,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage® Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada",Other,Assessment Document or Analysis,2022-11-16T05:00:00Z,2022,11,2022-11-16T05:00:00Z,,2022-11-16T17:45:01Z,,0,0,09000064854bb7e3